First-In-Human Trial Of Cb-010, A Crispr-Edited Allogeneic Anti-Cd19 Car -T Cell Therapy With A Pd-1 Knock Out, In Patients With Relapsed Or Refractory B Cell Non-Hodgkin Lymphoma (Antler Study)
CB-010
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: First-In-Human Trial Of Cb-010, A Crispr-Edited Allogeneic Anti-Cd19 Car -T Cell Therapy With A Pd-1 Knock Out, In Patients With Relapsed Or Refractory B Cell Non-Hodgkin Lymphoma (Antler Study) ### Output: CB-010